Our results align with previous studies that reported protective effects against diet-induced non-alcoholic steatohepatitis (NASH) in mice lacking whole-body expression of MAdCAM-1 or treated with α4β7 or MAdCAM-1 mAbs [6,19]. Here, MADCAM1 is linked to metabolic dysfunction-associated steatohepatitis.